SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020018
Filing Date
2018-08-07
Accepted
2018-08-07 17:02:21
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20180630.htm 10-Q 1975636
2 EX-10.3 xene-ex103_114.htm EX-10.3 75978
3 EX-31.1 xene-ex311_8.htm EX-31.1 18939
4 EX-31.2 xene-ex312_6.htm EX-31.2 19002
5 EX-32.1 xene-ex321_9.htm EX-32.1 11666
6 EX-32.2 xene-ex322_7.htm EX-32.2 11303
  Complete submission text file 0001564590-18-020018.txt   5415080

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT xene-20180630.xml EX-101.INS 911184
8 XBRL TAXONOMY EXTENSION SCHEMA xene-20180630.xsd EX-101.SCH 41057
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20180630_cal.xml EX-101.CAL 38612
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20180630_def.xml EX-101.DEF 143089
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20180630_lab.xml EX-101.LAB 291065
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20180630_pre.xml EX-101.PRE 231664
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 18998910
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences